Solitaire™ X 急性期脳梗塞に対する血栓回収療法

^{1. Medtronic Data on File. Solitaire Literature Review Aug2022.}

^{2. HERMES: Goyal M, Menon BK, van Zwam WH, et al. Endovascular thrombectomy after large-vessel ischaemic stroke: A meta-analysis of individual patient data from five randomised trials. Lancet. 2016;387(10029):1723-1731.}

^{3. SWIFT DIRECT: Fischer U, Kaesmacher J, Strbian D, et al. Thrombectomy alone versus intravenous alteplase plus thrombectomy in patients with stroke: An open-label, blinded-outcome, randomised non-inferiority trial. Lancet. 2022; 400(10346):104-115.}

^{4. STRATIS: Mueller-Kronast NH, Zaidat OO, Froehler MT, et al. Systematic evaluation of patients treated with neurothrombectomy devices for acute ischemic stroke: primary results of the STRATIS registry. Stroke. 2017;48(10):2760-2768.}

^{5. ESCAPE: Goyal M, Demchuk AM, Menon BK, et al. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med. 2015;372(11):1019-1030.}

^{6. SWIFT PRIME: Saver JL, Goyal M, Bonafe A, et al. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med. 2015;372(24):2285-2295.}

^{7. Nasa Registry: Nguyen TN, Malisch T, Castonguay AC, et al. Balloon guide catheter improves revascularization and clinical outcomes with the Solitaire device: Analysis of the North American Solitaire Acute Stroke Registry. Stroke. 2014;45(1):141-145.}

^{8. RESILIENT: Martins SO, Mont’Alverne F, Rebello LC, et al. Thrombectomy for stroke in the public health care system of Brazil. N Engl J Med. 2020;382(24):2316-2326.}

^{9. Economic Evaluation: Lylyk P, Cirio J, Toranzo C, Aiello E, Valencia J, Paredes-Fernández D. Mechanical thrombectomy for acute ischemic stroke due to large vessel occlusion in Argentina: An economic analysis. J Stroke Cerebrovasc Dis. 2022;31(8):106595.}

^{10. THRACE: Bracard S, et al. Bracard S, Ducrocq X, Mas JL, et al. Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRACE): A randomised controlled trial [published correction appears in Lancet Neurol. 2016 Nov;15(12):1203]. Lancet Neurol. 2016;15(11):1138-1147.}

^{11. REVASCAT: Jovin TG, Chamorro A, Cobo E, et al. Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med. 2015;372(24):2296-2306.}

^{12. MR CLEAN: Berkhemer OA, Fransen PS, Beumer D, et al. A randomized trial of intraarterial treatment for acute ischemic stroke [published correction appears in N Engl J Med. 2015 Jan 22;372(4):394]. N Engl J Med. 2015;372(1):11-20.}

^{13. STAR: Pereira VM, et al. Pereira VM, Gralla J, Davalos A, et al. Prospective, multicenter, single-arm study of mechanical thrombectomy using Solitaire Flow Restoration in acute ischemic stroke [published correction appears in Stroke. 2013 Dec;44(12):e239. Moreno, Alfredo [corrected to Moreno, Antonio]] [published correction appears in Stroke. 2021 Jan; 52(1):e48]. Stroke. 2013;44(10):2802-2807.}

^{14. BEYOND SWIFT: Meinel TR, Kaesmacher J, Mordasini P, et al. Outcome, efficacy and safety of endovascular thrombectomy in ischaemic stroke according to time to reperfusion: Data from a multicentre registry. Ther Adv Neurol Disord. 2019;12:1756286419835708.}

^{15. EXTEND-IA: Campbell BC, Mitchell PJ, Kleinig TJ, et al. Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med. 2015; 372(11):1009-1018.}

^{16. SEER: Campbell BC, Hill MD, Rubiera M, et al. Safety and efficacy of solitaire stent thrombectomy: Individual patient data meta-analysis of randomized trials. Stroke. 2016;47(3):798-806.}

^{17 .M003592CDOC2;}

^{18. D00419703 Rev A;}

^{19. D00324045 Rev A}

^{*1 TR-NV16168 Rev A; Compared to Solitaire™ Platinum}

^{*2 DWGSFG13XXX-YYyy-Zz Rev B; DWGSFG15XXX-YYyy-Zz Rev B;}

^{販売名: Solitaire X 血栓回収デバイス
医療機器承認番号: 30200BZX00148000}

^{使用目的又は効果、警告・禁忌を含む使用上の注意等の情報につきましては製品の電子添文をご参照ください。}